223 related articles for article (PubMed ID: 34902374)
41. Endoscopic Ultrasound-Guided Radiofrequency Ablation of the Pancreatic Tumors: A Promising Tool in Management of Pancreatic Tumors.
Changela K; Patil R; Duddempudi S; Gaduputi V
Can J Gastroenterol Hepatol; 2016; 2016():4189358. PubMed ID: 27478820
[TBL] [Abstract][Full Text] [Related]
42. Small pancreatic insulinoma: Successful endoscopic ultrasound-guided radiofrequency ablation in a single session using a 22-G fine needle.
Bas-Cutrina F; Bargalló D; Gornals JB
Dig Endosc; 2017 Jul; 29(5):636-638. PubMed ID: 28295664
[No Abstract] [Full Text] [Related]
43. EUS-guided alcohol ablation of an insulinoma.
Jürgensen C; Schuppan D; Neser F; Ernstberger J; Junghans U; Stölzel U
Gastrointest Endosc; 2006 Jun; 63(7):1059-62. PubMed ID: 16733126
[TBL] [Abstract][Full Text] [Related]
44. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis.
Khoury T; Sbeit W; Fusaroli P; Campana D; Brighi N; Napoleon B; Lisotti A
Dig Endosc; 2024 Apr; 36(4):395-405. PubMed ID: 37702096
[TBL] [Abstract][Full Text] [Related]
45. Successful EUS-guided ethanol ablation of insulinoma, four-year follow-up. Case report and literature review.
Dąbkowski K; Gajewska P; Walter K; Londzin-Olesik M; Białek A; Andrysiak-Mammos E; Kos-Kudła B; Starzyńska T
Endokrynol Pol; 2017; 68(4):472-479. PubMed ID: 28819950
[TBL] [Abstract][Full Text] [Related]
46. EUS-guided ethanol ablation of symptomatic pancreatic insulinomas.
Yang D; Inabnet WB; Sarpel U; DiMaio CJ
Gastrointest Endosc; 2015 Dec; 82(6):1127. PubMed ID: 26232361
[No Abstract] [Full Text] [Related]
47. Endoscopic ultrasound-guided lymph node ablation with a novel radiofrequency ablation probe: feasibility study in an acute porcine model.
Sethi A; Ellrichmann M; Dhar S; Hadeler KG; Kahle E; Seehusen F; Klapper W; Habib N; Fritscher-Ravens A
Endoscopy; 2014 May; 46(5):411-5. PubMed ID: 24505019
[TBL] [Abstract][Full Text] [Related]
48. Echoendoscopic ablative therapy for solid pancreatic tumors.
Paik WH; Seo DW
J Dig Dis; 2017 Mar; 18(3):135-142. PubMed ID: 28133944
[TBL] [Abstract][Full Text] [Related]
49. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a case series.
de Nucci G; Imperatore N; Mandelli ED; di Nuovo F; d'Urbano C; Manes G
Endosc Int Open; 2020 Dec; 8(12):E1754-E1758. PubMed ID: 33269307
[No Abstract] [Full Text] [Related]
50. Endosonography-guided Radiofrequency Ablation in Pancreatic Diseases: Time to Fill the Gap Between Evidence and Enthusiasm.
Vanella G; Capurso G; Arcidiacono PG
J Clin Gastroenterol; 2020 Aug; 54(7):591-601. PubMed ID: 32482951
[TBL] [Abstract][Full Text] [Related]
51. [Identification of insulinomas by endoscopic ultrasonography].
Ardengh JC; Valiati LH; Geocze S
Rev Assoc Med Bras (1992); 2004; 50(2):167-71. PubMed ID: 15286865
[TBL] [Abstract][Full Text] [Related]
52. EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer: a randomized controlled trial (with videos).
Bang JY; Sutton B; Hawes RH; Varadarajulu S
Gastrointest Endosc; 2019 Jan; 89(1):58-66.e3. PubMed ID: 30120957
[TBL] [Abstract][Full Text] [Related]
53. EUS-guided fine needle tattooing (EUS-FNT) for preoperative localization of small pancreatic neuroendocrine tumors (p-NETs): a single-center experience.
Rosa F; Rimbaș M; Rizzatti G; Quero G; Fiorillo C; Impagnatiello M; D'Aversa F; Costamagna G; Alfieri S; Larghi A
Surg Endosc; 2021 Jan; 35(1):486-492. PubMed ID: 32959183
[TBL] [Abstract][Full Text] [Related]
54. Successful endoscopic ultrasound-guided radiofrequency ablation of a pancreatic insulinoma.
Kluz M; Staroń R; Krupa Ł; Partyka M; Polkowski M; Gutkowski K
Pol Arch Intern Med; 2020 Feb; 130(2):145-146. PubMed ID: 31820740
[No Abstract] [Full Text] [Related]
55. Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery.
Law JK; Singh VK; Khashab MA; Hruban RH; Canto MI; Shin EJ; Saxena P; Weiss MJ; Pawlik TM; Wolfgang CL; Lennon AM
Surg Endosc; 2013 Oct; 27(10):3921-6. PubMed ID: 23636530
[TBL] [Abstract][Full Text] [Related]
56. EUS-guided lauromacrogol ablation of insulinomas: a novel treatment.
Qin S; Liu Y; Ning H; Tao L; Luo W; Lu D; Luo Z; Qin Y; Zhou J; Chen J; Jiang H
Scand J Gastroenterol; 2018 May; 53(5):616-620. PubMed ID: 29141488
[TBL] [Abstract][Full Text] [Related]
57. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors.
Pai M; Habib N; Senturk H; Lakhtakia S; Reddy N; Cicinnati VR; Kaba I; Beckebaum S; Drymousis P; Kahaleh M; Brugge W
World J Gastrointest Surg; 2015 Apr; 7(4):52-9. PubMed ID: 25914783
[TBL] [Abstract][Full Text] [Related]
58. Successful endoscopic ultrasound-guided ethanol ablation of multiple insulinomas accompanied with multiple endocrine neoplasia type 1.
Lee MJ; Jung CH; Jang JE; Hwang JY; Park DH; Park TS; Lee WJ
Intern Med J; 2013 Aug; 43(8):948-50. PubMed ID: 23919339
[No Abstract] [Full Text] [Related]
59. [Is endosonography-guided radiofrequency ablation of insulinoma a reasonable alternative to surgery?].
Wiese D; Bartsch DK
Chirurgie (Heidelb); 2023 Jun; 94(6):550-551. PubMed ID: 37140658
[No Abstract] [Full Text] [Related]
60. EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience.
Atiq M; Bhutani MS; Bektas M; Lee JE; Gong Y; Tamm EP; Shah CP; Ross WA; Yao J; Raju GS; Wang X; Lee JH
Dig Dis Sci; 2012 Mar; 57(3):791-800. PubMed ID: 21964743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
